Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Carrus Capital Corporation Closes Private Placement

BLKCF

(TheNewswire)

\

Vancouver, B.C. / TheNewswire / January 6, 2017 – Carrus Capital Corporation (TSX.V – CHQ) (the “Company”) announces that it has closed its private placement announced in its news release dated December 2, 2016. The Company has raised $500,000 through the distribution of 10,000,000 special warrants (“Special Warrants”) of the Company at a price of $0.05 per Special Warrant.  

 

Each Special Warrant entitles the holder to receive, without payment of any additional consideration or need for further action, one unit (“Unit”) of the Company, each Unit comprising of one common share (“Share”) and one share purchase warrant (“Warrant”); each Warrant entitling the holder to acquire one additional Share at $0.05 for a period of 24 months.  The Special Warrants will convert to Units on the earlier of: (i) four months and a day after closing of the placement; and (ii) the receipt of a final prospectus qualifying the Shares and underlying Warrants.

 

Finder’s fees of 731,200 Special Warrants were paid to two finders.

 

The securities issued in relation to this private placement are subject to regulatory four-month hold period expiring May 7, 2017.

 

The net proceeds of the offering, together with the Company’s current investment capital, will be used by the Company to expand its existing investment business.  The Company intends to pay down existing loans and investigate new investment opportunities in life sciences, including cannabis related businesses.

 

Closing of the private placement is subject to receipt of all necessary regulatory approvals, including approval of the TSX Venture Exchange.  

 

ON BEHALF OF THE BOARD

Chester Shynkaryk

Chief Executive Officer

Phone: 604-722-9140

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements.  This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States.

 

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Copyright (c) 2017 TheNewswire - All rights reserved.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today